Related Experiment Video
Updated: Jul 7, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
Dual role of proapoptotic BAD in insulin secretion and beta cell survival
Nika N Danial1, Loren D Walensky, Chen-Yu Zhang
1Department of Pathology, Harvard Medical School, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA. nika_danial@dfci.harvard.edu
Abstract:
The proapoptotic BCL-2 family member BAD resides in a glucokinase-containing complex that regulates glucose-driven mitochondrial respiration. Here, we present genetic evidence of a physiologic role for BAD in glucose-stimulated insulin secretion by beta cells. This novel function of BAD is specifically dependent upon the phosphorylation of its BH3 sequence, previously defined as an essential death domain. We highlight the pharmacologic relevance of phosphorylated BAD BH3 by using cell-permeable, hydrocarbon-stapled BAD BH3 helices that target glucokinase, restore glucose-driven mitochondrial respiration and correct the insulin secretory response in Bad-deficient islets. Our studies uncover an alternative target and function for the BAD BH3 domain and emphasize the therapeutic potential of phosphorylated BAD BH3 mimetics in selectively restoring beta cell function. Furthermore, we show that BAD regulates the physiologic adaptation of beta cell mass during high-fat feeding. Our findings provide genetic proof of the bifunctional activities of BAD in both beta cell survival and insulin secretion.
Insights
The proapoptotic protein BAD plays a key role in glucose-stimulated insulin secretion by beta cells, with its BH3 domain crucial for this function. Targeting phosphorylated BAD BH3 mimetics may restore beta cell function and regulate beta cell mass.
Area of Science:
- Molecular Biology
- Cellular Metabolism
- Endocrinology
Background:
- The BCL-2 family member BAD is known for its proapoptotic role.
- BAD interacts with glucokinase, influencing glucose-driven mitochondrial respiration.
Purpose of the Study:
- To investigate the physiological role of BAD in glucose-stimulated insulin secretion (GSIS) by beta cells.
- To explore the therapeutic potential of targeting BAD's BH3 domain for metabolic disorders.
Main Methods:
- Genetic studies in beta cells to assess BAD's function in GSIS.
- Utilizing cell-permeable, hydrocarbon-stapled BAD BH3 helices as pharmacological tools.
- Assessing mitochondrial respiration and insulin secretion in BAD-deficient islets.
Main Results:
- Genetic evidence confirms BAD's crucial role in GSIS, dependent on BH3 sequence phosphorylation.
- Phosphorylated BAD BH3 mimetics restored mitochondrial respiration and corrected insulin secretion in deficient islets.
- BAD was found to regulate beta cell mass adaptation during high-fat feeding.
Conclusions:
- BAD possesses bifunctional activities, regulating both beta cell survival and insulin secretion.
- The BAD BH3 domain has an alternative function in regulating glucose metabolism and insulin release.
- Phosphorylated BAD BH3 mimetics represent a potential therapeutic strategy for enhancing beta cell function.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin Secretory Vesicles
The Intrinsic Apoptotic Pathway
Type I Diabetes II: Pathophysiology
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...

